Advanced search
Publication Cover
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders Volume 1, 2000 - Issue 5
Journal homepage
404
Views
47
CrossRef citations to date
0
Altmetric
Research Article

Improving the quality of life for people with ALS: The challenge ahead

Hiroshi Mitsumoto Director, Eleanor & Lou Gehrig MDA/ALS Center, The Neurological Institute, Columbia-Presbyterian Medical Center, New York, NY, USA
&
Maura Del Bene Clinical Administrator, Eleanor & Lou Gehrig MDA/ALS Center, The Neurological Institute, Columbia-Presbyterian Medical Center, New York, NY, USA
Pages 329-336 | Published online: 10 Jul 2009

  • Ruta DA, Carratt AM, Leng M, Russell IT, MacDonald LM. A new approach to the measurement of quality of life: the patient-generated index. Med Care 1994; 32:1109-1126.
  • Gill TM, Feinstein AR. A critical appraisal of the quality of qualily-of-life measurements. JAMA 1994; 272: 619-626.
  • Murrell R. Quality of life and neurological illness: a review of the literature. Neuropsychol Rev (in press).
  • Lai EC, Felice KJ, Festoff BW, et al. Effect of recombinant human insulin-like growth factor-I on progression of ALS. A placebo-controlled study. Neurology 1997; 49: 1621-1630.
  • McGuire D, Garrison L, Armon C, et al. A brief qualily-of-life measure for ALS clinical trials. Based on a subset of items from the sickness impact profile. J Neurol Sei 1997; 152:S18-S22.
  • Miller RG, Anderson F, ALS C.A.R.E Study Group. Assessing Quality of Life in ALS: Comparison of the Short Form-12 Health Survey(tm) with the ALS Functional Rating Scale, Forced Vital Capacity, and ALS Quality of life Index. 8th International Symposium on ALS/MND; November 3-5, 1997, Glasgow, Scotland [poster].
  • Wright L The long and the short of it development of the SF-36 general health survey. In: Jenkinson C (Ed). Measuring Health and Medical Outcomes. London UCL Press, 1994.
  • BDNF Study Group (Phase III). A controlled trial of recombinant methionyl human BDNF in ALS. Neurology 1999; 52: 1427-1433.
  • Miller RG, Anderson F, Bradley W, et al. The ALS Patient Care Database I: Goals, structure and early results. Neurology 2000; 54: 53-57.
  • Simmons Z, Robbins RA, Bremer BA, et al. Longitudinal relationship between quality of life, physical function, and spirituality in patients with ALS. 10th International Symposium of ALS/MND, Vancouver 1999: 9-10 (abstr).
  • O'Boyle C, McGee H, Hickey A, O'Maley K, Joyce CRB. Individual quality of life in patients undergoing hip-replacement Lancet 1992; 339: 1088-1091.
  • Jenkinson C, Fitzpatrick R, Brennan C, Swash M. Evidence for the validity and reliability of the ALS assessment questionnaire: The ALSAQ-40. ALS 1999; 1: 33-40.
  • ALS CNTF Treatment Study (ACTS) Phase I-II Study Group. The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. Arch Neurol 1996; 53: 141-147.
  • Miller RG, Rosenberg JA, Gelinas DF, et al. Practice parameter: an evidence-based review. Neurology 1999; 52: 1311-1323.
  • Beisecker AE, Kuckelmann-Cobb A, Ziegler DK. Patients' perspectives of the role of care providers in amyotrophic lateral sclerosis. Arch Neurol 1988; 45: 553-556.
  • Mitsumoto H, Chad DA, Pioro EP. Comprehensive care; and medical economics, legality, and medical ethics in ALS. In: Amyotrophic Lateral Sclerosis. Contemporary Neurology Series 49. New York: Oxford Press, 1998: 305-320; 448-464.
  • Mitsumoto H, Shockley L. Amyotrophic lateral sclerosis: continuum of care from diagnosis through hospice. Home HealthCare Consultant 1998; 5: 20-29.
  • Mitsumoto H. and Morris FT, Jr. Amyotrophic Lateral Sclerosis: Comprehensive Management and Treatment New York Demos, 1994.
  • DaI Bello-Haas V, Moos AD, Mitsumoto H. Physical therapy for a patient through six stages of amyotrophic lateral sclerosis. Phys Ther 1998; 78:1312-1324.
  • Mitsumoto H. Patient choices in ALS: Life-sustaining treatment versus palliative care? Neurology 1999; 53: 248-249.
  • Lacomblez L, Bensimon G, Leigh NP, et al for the Amyotrophic Lateral Sclerosis/Riluzole Study Croup II. Doseranging study of riluzole in amyotrophic lateral sclerosis. Lancet 1996; 347: 1425-1431.
  • Miller RG, Sufit R, Mitsumoto H, Gelinus DF, Brooks BR. ALS standard of care consensus. Neurology 1997; 48(Suppl 4): S33-S37.
  • Mitsumoto H. Riluzole--what is its impact in our treatment and understanding of amyotrophic lateral sclerosis? Ann Pharmacother 1997; 31: 779-781.
  • Noms FH. Treating the untreated. Br Med J 1992; 304: 459-460
  • Mazzini L, Corra T, Zaccala M, Mora C, DelPiano M, Galante M. Percutaneous endoscopie gastrostomy and enterai nutrition in amyotrophic lateral sclerosis. J Neurol 1995; 242: 695-698.
  • Kasarskis EJ, Scarlata D, Hill R, et al. A retrospective study of percutaneous endoscopie gastrostomy. I ALS patients during the BDNF and CNTF trials. J Neurol Sei 1999; 169: 118-125.
  • Aboussaouan LS, Khan SU, Meeker DP, Stelmack K, Mitsumoto H. The effect of non-invasive positive pressure ventilation on survival in amyotrophic lateral sclerosis. Ann Intern Med 1997; 127: 450-453.
  • Kleopa KA, Sherman M, Neil B, Romano GJ, Heiman-Patterson T. Bipap improves survival and rate of pulmonary function decline in patients with ALS. J Neurol Sci 1999; 164: 82-88.
  • MeIo J, Homma A, Iturriag E, et al. Pulmonary evaluation and prevalence of non-invasive ventilation in patients with amyotrophic lateral sclerosis: a multicenter survey and proposal of a pulmonary protocol. J Neurol Sd 1999; 169: 114-117.
  • Pinto AC, Evangelista T, Carvalho M, et al. Respiratory assistance with a non-invasive ventilator (BiPAP) in MND/ALS patients: survival rates in a controlled trial. J Neurol Sci 1995; 129 (suppl): 19-26.
  • Sivak ED, Shefner JM, Mitsumoto H. The use of noninvasive positive pressure ventilation (NIPPV) in the treatment of respiratory failure in ALS patients. A need for better definition of timing of the goals of intervention. J Neurol Sd (in press).
  • Aboussouan LS, Khan SU, Arroliga AC, Banerji M, Mitsumoto H. Effect of non-invasive pressure ventilation on pulmonary function in ALS. Chest 1999; 116: 271S.
  • Albert SM, Murphy PL, Del Bene ML, Rowland LP. Prospective study of palliative care in ALS: choice, timing, outcomes. J Neurol Sci 1999; 169: 108-113.
  • Albert SM, Murphy PL, DelBene MI, Rowland LP. A prospective study of preferences and actual treatment choices in ALS. Neurology 1999; 53: 273-284.
  • Mandler RN, Clawson LL, Miller RG, and the ALS C.A.R.E. Study Croup. The ALS Patient Care Database--Insights into end-of-life palliative care. American Neurological Association 124th Annual Meeting, Seattle, Washington, 1999 [poster].
  • Moss AH, Casey P, Stocking CB, et al. Home ventilator for amyotrophic lateral sclerosis patient: outcomes, costs, and patients, family, and physician attitude. Neurology 1993; 43: 438-443.
  • Kowa H. Home care system in amyotrophic lateral sclerosis. Neurol Therap (Tokyo) 1993; 10: 279-283.
  • Krivickas LS, Shockley L, Mitsumoto H. Home care of patients with amyotrophic lateral sclerosis (ALS). J Neurol Sei 1997; 152 (Suppl 1): S82-S89.
  • Borasio GD, Volte R. Palliative care in amyotrophic lateral sclerosis. J Neurol 1997; 244 (suppl 4): SIl-Sl7.
  • O'Brien T. Palliative care and taboos within motor neurone disease. Palliat Med 1993; 7(suppl 2): 69-72.
  • McDonald ER, Wiedenfeld SA, Hillel A, Carpenter CL, Walter RA. Survival in amyotrophic lateral sclerosis. Arch Neurol 1994; 51: 17-23.
  • Rabkin JG, Wagner GJ, Del Bene M. Resilience and distress among amyotrophic lateral sclerosis patients and caregivers. Psychosom Med (in press).
  • Lyon M. Living with ALS - HOPE LINK 1998; 12.
  • Miller RG, Munsat IL, Swash M, Brooks BR Consensus guidelines for the design and implementation of clinical trials in ALS. J Neurol Sd 1999; 196: 2-12.
  • Bach JR. Ventilator use by muscular dystrophy association patients. Arch Phys Med Rehabil 1992; 73:179-183.
  • Anderson FA Jr, Miller RG, ALS GARE Advisory board. A resource for measuring and improving ALS outcomes. Neurology 1996; 47 (suppl 2): Sl13-Sl16.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.